Agmatine protects Müller cells from high‑concentration glucose‑induced cell damage via N‑methyl‑D‑aspartic acid receptor inhibition

Han,Ning; Yu,Li; Song,Zhidu; Luo,Lifu; Wu,Yazhen

doi:10.3892/mmr.2015.3540

Agmatine protects Müller cells from high‑concentration glucose‑induced cell damage via N‑methyl‑D‑aspartic acid receptor inhibition

Authors:
- Ning Han
- Li Yu
- Zhidu Song
- Lifu Luo
- Yazhen Wu
View Affiliations

Affiliations: Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Department of Ocular Fundus Disease, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
Published online on: March 24, 2015 https://doi.org/10.3892/mmr.2015.3540
Pages: 1098-1106
Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neural injury is associated with the development of diabetic retinopathy. Müller cells provide structural and metabolic support for retinal neurons. High glucose concentrations are known to induce Müller cell activity. Agmatine is an endogenous polyamine, which is enzymatically formed in the mammalian brain and has exhibited neuroprotective effects in a number of experimental models. The aims of the present study were to investigate whether agmatine protects Müller cells from glucose‑induced damage and to explore the mechanisms underlying this process. Lactate dehydrogenase activity and tumor necrosis factor‑α mRNA expression were significantly reduced in Müller cells exposed to a high glucose concentration, following agmatine treatment, compared with cells not treated with agmatine. In addition, agmatine treatment inhibited glucose‑induced Müller cell apoptosis, which was associated with the regulation of Bax and Bcl‑2 expression. Agmatine treatment suppressed glucose‑induced phosphorylation of mitogen‑activated protein kinase (MAPK) protein in Müller cells. The present study demonstrated that the protective effects of agmatine on Müller cells were inhibited by N‑methyl‑D‑aspartic acid (NMDA). The results of the present study suggested that agmatine treatment protects Müller cells from high‑concentration glucose‑induced cell damage. The underlying mechanisms may relate to the anti‑inflammatory and antiapoptotic effects of agmatine, as well as to the inhibition of the MAPK pathway, via NMDA receptor suppression. Agmatine may be of use in the development of novel therapeutic approaches for patients with diabetic retinopathy.

View Figures

View References

1	Congdon N, O’Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR and Mitchell P: Eye Diseases Prevalence Research Group: Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122:477–485. 2004. View Article : Google Scholar : PubMed/NCBI
2	Lieth E, Gardner TW, Barber AJ and Antonetti DA: Penn State Retina Research Group: Retinal neurodegeneration: Early pathology in diabetes. Clin Experiment Ophthalmol. 28:3–8. 2000. View Article : Google Scholar
3	Schellini SA, Gregório EA, Spadella CT, Machado JL and de-Moraes-Silva MA: Müller cells and diabetic retinopathy. Braz J Med Biol Res. 28:977–980. 1995.PubMed/NCBI
4	Newman E and Reichenbach A: The Müller cell: A functional element of the retina. Trends Neurosci. 19:307–312. 1996. View Article : Google Scholar : PubMed/NCBI
5	Du JL, Xu LY and Yang XL: Glycine receptors and transporters on bullfrog retinal Müller cells. Neuroreport. 13:1653–1656. 2002. View Article : Google Scholar : PubMed/NCBI
6	Lewis GP, Erickson PA, Kaska DD and Fisher SK: An immunocytochemical comparison of Müller cells and astrocytes in the cat retina. Exp Eye Res. 47:839–853. 1988. View Article : Google Scholar : PubMed/NCBI
7	Linser P and Moscona AA: Induction of glutamine synthetase in embryonic neural retina: Localization in Müller fibers and dependence on cell interactions. Proc Natl Acad Sci USA. 76:6476–6480. 1979. View Article : Google Scholar
8	Li Q and Puro DG: Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells. Invest Ophthalmol Vis Sci. 43:3109–3116. 2002.PubMed/NCBI
9	Kowluru RA, Engerman RL, Case GL and Kern TS: Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int. 38:385–390. 2001. View Article : Google Scholar : PubMed/NCBI
10	Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D and Strother JM: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes. 47:815–820. 1998. View Article : Google Scholar : PubMed/NCBI
11	Barber AJ, Antonetti DA and Gardner TW: Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci. 41:3561–3568. 2000.PubMed/NCBI
12	Rungger-Brändle E, Dosso AA and Leuenberger PM: Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 41:1971–1980. 2000.PubMed/NCBI
13	Li Q, Zemel E, Miller B and Perlman I: Early retinal damage in experimental diabetes: Electroretinographical and morphological observations. Exp Eye Res. 74:615–625. 2002. View Article : Google Scholar : PubMed/NCBI
14	Curtis TM, Hamilton R, Yong PH, McVicar CM, Berner A, Pringle R, Uchida K, Nagai R, Brockbank S and Stitt AW: Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Diabetologia. 54:690–698. 2011. View Article : Google Scholar
15	Zhong Y, Li J, Chen Y, Wang JJ, Ratan R and Zhang SX: Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes. Diabetes. 61:492–504. 2012. View Article : Google Scholar : PubMed/NCBI
16	Walker RJ and Steinle JJ: Role of beta-adrenergic receptors in inflammatory marker expression in Müller cells. Invest Ophthalmol Vis Sci. 48:5276–5281. 2007. View Article : Google Scholar : PubMed/NCBI
17	Tabor CW and Tabor H: Polyamines. Annu Rev Biochem. 53:749–790. 1984. View Article : Google Scholar : PubMed/NCBI
18	Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R and Reis DJ: Agmatine: An endogenous clonidine-displacing substance in the brain. Science. 263:966–969. 1994. View Article : Google Scholar : PubMed/NCBI
19	Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA and Reis DJ: Regional localization of agmatine in the rat brain: An immunocytochemical study. Brain Res. 787:1–14. 1998. View Article : Google Scholar : PubMed/NCBI
20	Reis DJ, Yang XC and Milner TA: Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci Lett. 250:185–188. 1998. View Article : Google Scholar : PubMed/NCBI
21	Raasch W, Schäfer U, Chun J and Dominiak P: Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol. 133:755–780. 2001. View Article : Google Scholar : PubMed/NCBI
22	Piletz JE, Chikkala DN and Ernsberger P: Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 272:581–587. 1995.PubMed/NCBI
23	Yang XC and Reis DJ: Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther. 288:544–549. 1999.PubMed/NCBI
24	Satriano J, Kelly CJ and Blantz RC: An emerging role for agmatine. Kidney Int. 56:1252–1253. 1999. View Article : Google Scholar : PubMed/NCBI
25	Iizuka Y, Hong S, Kim CY, Kim SK and Seong GJ: Agmatine pretreatment protects retinal ganglion cells (RGC-5 cell line) from oxidative stress in vitro. Bio cell. 32:245–250. 2008.
26	Iizuka Y, Hong S, Kim CY, Yang WI, Lee JE and Seong GJ: Protective mechanism of agmatine pretreatment on RGC-5 cells injured by oxidative stress. Braz J Med Biol Res. 43:356–358. 2010. View Article : Google Scholar : PubMed/NCBI
27	Park YM, Lee WT, Bokara KK, Seo SK, Park SH, Kim JH, Yenari MA, Park KA and Lee JE: The multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2/4/7 expressions in neurons and glial cells. PLoS One. 8:e539112013. View Article : Google Scholar : PubMed/NCBI
28	Ahn SK, Hong S, Park YM, Choi JY, Lee WT, Park KA and Lee JE: Protective effects of agmatine on lipopolysac-charide-injured microglia and inducible nitric oxide synthase activity. Life Sci. 91:1345–1350. 2012. View Article : Google Scholar : PubMed/NCBI
29	Uchihori Y and Puro DG: Glutamate as a neuron-to-glial signal for mitogenesis: Role of glial N-methyl-D-aspartate receptors. Brain Res. 613:212–220. 1993. View Article : Google Scholar : PubMed/NCBI
30	Mysona BA, Al-Gayyar MM, Matragoon S, Abdelsaid MA, El-Azab MF, Saragovi HU and El-Remessy AB: Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats. Diabetologia. 56:2329–2339. 2013. View Article : Google Scholar : PubMed/NCBI
31	Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, et al: Agmatine: Clinical applications after 100 years in translation. Drug Discov Today. 18:880–893. 2013. View Article : Google Scholar : PubMed/NCBI
32	Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpció Boronat M, Trullas R, Villarroel A, Lerma J and García-Sevilla JA: Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol. 127:1317–1326. 1999. View Article : Google Scholar : PubMed/NCBI
33	Hong S, Kim CY, Lee JE and Seong GJ: Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life Sci. 84:28–32. 2009. View Article : Google Scholar
34	Hong S, Lee JE, Kim CY and Seong GJ: Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci. 8:812007. View Article : Google Scholar : PubMed/NCBI
35	Zhu MY, Wang WP and Bissette G: Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience. 141:2019–2027. 2006. View Article : Google Scholar : PubMed/NCBI
36	Kawabata H, Setoguchi T, Yone K, Souda M, Yoshida H, Kawahara K, Maruyama I and Komiya S: High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine (Phila Pa 1976). 35:1109–1115. 2010.
37	McNearney TA, Ma Y, Chen Y, Taglialatela G, Yin H, Zhang R and Westlund KN: A peripheral neuroimmune link: Glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes. Am J Physiol Regul Integr Comp Physiol. 298:R584–R598. 2010. View Article : Google Scholar
38	Kern TS and Barber AJ: Retinal ganglion cells in diabetes. J Physiol. 586:4401–4408. 2008. View Article : Google Scholar : PubMed/NCBI
39	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
40	Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440–442. 1988. View Article : Google Scholar : PubMed/NCBI
41	Ola MS, Nawaz M and Ahsan H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
42	Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
43	Youle RJ and Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 9:47–59. 2008. View Article : Google Scholar
44	Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ and Los M: Apoptosis and cancer: Mutations within caspase genes. J Med Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
45	Ko HW, Park KY, Kim H, Han PL, Kim YU, Gwag BJ and Choi EJ: Ca²⁺-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J Neurochem. 71:1390–1395. 1998. View Article : Google Scholar : PubMed/NCBI
46	Nicole O, Ali C, Docagne F, Plawinski L, MacKenzie ET, Vivien D and Buisson A: Neuroprotection mediated by glial cell line-derived neurotrophic factor: Involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci. 21:3024–3033. 2001.PubMed/NCBI
47	Munemasa Y, Ohtani-Kaneko R, Kitaoka Y, Kuribayashi K, Isenoumi K, Kogo J, Yamashita K, Kumai T, Kobayashi S, Hirata K and Ueno S: Contribution of mitogen-activated protein kinases to NMDA-induced neurotoxicity in the rat retina. Brain Res. 1044:227–240. 2005. View Article : Google Scholar : PubMed/NCBI
48	Kundu S, Pushpakumar SB, Tyagi A, Coley D and Sen U: Hydrogen sulfide deficiency and diabetic renal remodeling: Role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab. 304:E1365–E1378. 2013. View Article : Google Scholar : PubMed/NCBI